INmune Bio Inc.

NASDAQ: INMB · Real-Time Price · USD
2.53
0.08 (3.27%)
At close: Aug 15, 2025, 3:59 PM
2.47
-2.37%
After-hours: Aug 15, 2025, 07:51 PM EDT

INmune Bio Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-42.08M -30.01M -27.3M -30.34M
Depreciation & Amortization
n/a n/a n/a n/a
Stock-Based Compensation
7.61M 7.37M 7.15M 4.8M
Other Working Capital
1.38M 1.7M -4.27M -5.35M
Other Non-Cash Items
79K 224K 328K 126K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
1.04M 10.44M -2.86M -3.09M
Operating Cash Flow
-33.36M -11.98M -22.69M -28.5M
Capital Expenditures
n/a n/a n/a -15M
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
n/a n/a n/a -15M
Debt Repayment
-10M -5M n/a 14.95M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
422K n/a 30K 1.15M
Financial Cash Flow
18.21M -4.22M 729K 96.36M
Net Cash Flow
-14.93M -16.3M -22.66M 52.84M
Free Cash Flow
-33.36M -11.98M -22.69M -43.5M